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Abstract
Background Antibiotics are commonly given for the treatment of childhood diarrhoea,
but are not indicated in most cases. Antibiotics modify the gastrointestinal microbiota,
which may have unanticipated effects on the risk of subsequent diarrhoea.
Methods In a prospective observational cohort study, we assessed the effect of care-
giver-reported antibiotic treatment for diarrhoea on the timing of a child’s next episode
among 434 children followed from birth to 3 years of age in Vellore, India. We estimated
median time differences and time ratios from inverse probability of exposure-weighted
Kaplan-Meier curves for the time to next diarrhoea episode, comparing children who did
and did not receive antibiotics for the previous episode.
Results Study children had more than five diarrhoea episodes on average in the first 3
years of life, and more than a quarter of all episodes were treated with antibiotics.
Children who received antibiotics for their first diarrhoea episode had their second epi-
sode on average 8 weeks earlier (median time difference: 8, 95% confidence interval:
10, 3) than children who did not receive antibiotics. The effects of antibiotics on sub-
sequent diarrhoea were greatest at earlier episodes and younger ages, and cefixime had
a slightly larger effect compared with cotrimoxazole.
Conclusions Antibiotic treatment of diarrhoea was associated with reduced time to a subse-
quent diarrhoea episode, especially among younger infants. Whereas rational use of antibi-
otics has been advocated to reduce antimicrobial resistance in populations, we show that
overuse of antibiotics may also have a direct adverse effect on individual patients.
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Introduction
Diarrhoea is a universal and recurring disease during child-
hood, with the highest burden in low- and middle-income
countries. In 2010, the global incidence of diarrhoea before
age 5 years was estimated to be 2.7 episodes per child-year,
which corresponded to approximately 1.7 billion total epi-
sodes and resulted in 700 000 deaths.1
Antibiotics are widely accessible and commonly used
for the treatment of childhood diarrhoea in India.
However, international and Indian organizations, includ-
ing the World Health Organization, recommend against
routine use of antibiotics to treat diarrhoea.2,3 Antibiotics
are generally contraindicated for non-bloody diarrhoeas
because they are ineffective against non-bacterial and
resistant pathogens, and most episodes of diarrhoea are
self-limiting.4,5 Despite these arguments, several healthcare
facility-based studies in India have reported antibiotic
prescription rates for acute childhood diarrhoea from 50%
to 90%.6–9 In a nationwide community-based survey, 16%
of children under 5 years who had diarrhoea in the 2 weeks
preceding survey reported treatment with antibiotics, and
another 30% reported treatment with unknown drugs that
may have included antibiotics.10
Major concerns about inappropriate antibiotic use often
focus on the development of pathogen resistance to antibi-
otics, but direct harm to patients is also possible and often
overlooked.11 Specifically, antibiotics may disrupt the gastro-
intestinal (GI) microbiota—the complex community of
microorganisms inhabiting the human GI tract—by causing a
sharp reduction in the abundance and diversity of organ-
isms.12,13 This disruption can be prolonged, and the recovery
of the microbiota following antibiotic exposure is often in-
complete.14,15 The microbiota is important for the develop-
ment of the immune system,16,17 and may protect against
diarrhoeal disease by occupying intestinal mucosal sites and
inhibiting the attachment and growth of pathogens.18–20
Studies of the impact of antibiotics on diarrhoea most
often focus on the incidence of antibiotic-associated diar-
rhoea (AAD) occurring within 8 weeks of antibiotic expos-
ure,21,22 and often among hospitalized adults in developed
countries.23 Longitudinal investigation of the effects of
antibiotics on diarrhoeal risk has not been completed
among children in the developing world. In a birth cohort
of children from Vellore, India, we assessed the effect of
antibiotic treatment for diarrhoea on the timing of a child’s
next diarrhoea episode.
Methods
We analysed data from a prospective observational cohort
study on immune responses to cryptosporidiosis in 497
children followed from birth to 3 years of age from 2009
to 2013. The study population, enrolment strategy and
data collection methods have been described previously.24
Briefly, baseline information on demography, socioeco-
nomic indicators, health-seeking behaviour, environment,
diet and characteristics of delivery were collected within
45 days of birth. Fieldworkers interviewed caregivers twice
per week about any illnesses since the previous visit.
Clinical characteristics of the diarrhoea episodes were re-
corded, including the number of stools per day, consistency
and colour of stools, fever or vomiting, associated hospital-
ization and treatments given. Heights and weights were
measured monthly at the study clinic, and breastfeeding
histories (exclusive, non-exclusive, none) were collected
every 2 weeks until breastfeeding was stopped completely.
Data and definitions
Diarrhoea was defined using the standard World Health
Organization (WHO) definition as at least three loose or
watery stools in a 24-h period.2 Duration of a diarrhoea
episode was defined as the number of days from the first
day of watery stools until the last day of watery stools in-
clusive. A new episode of diarrhoea was defined only after
at least 48 h of normal bowel movements since the previ-
ous episode. Person-time at risk was defined as all days
during follow-up excluding days with diarrhoea and 48 h
after an episode of diarrhea, during which a new episode
of diarrhoea could not be defined.
Severity of diarrhoea was assessed using the 20-point
Vesikari scale.25 Episodes were classified as mild (1–5),
Key Messages
• Children who were treated with antibiotics for diarrhoea early in life experienced subsequent diarrhoea sooner than
children who were not treated with antibiotics.
• Exposure to antibiotics within the first 6 months of life was associated with the largest increases in diarrhoeal risk.
• These effects may be due to antibiotic-induced modifications to the composition of microorganisms in the gut.
• These results support recommendations for reduced and rational use of antibiotics.
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moderate (6–10), severe (11–15) and very severe (16–20).
Episodes were classified as acute if lasting 0–6 days or pro-
longed/persistent if lasting for 7 or more days.
The primary exposure was antibiotic treatment for diar-
rhoea based on caregiver report during the episode. A yes/
no question was asked specifically about whether antibi-
otics were given and the name of the drug(s) was recorded
if known (available for 64.0% of antibiotic reports). We
also extracted antibiotic prescriptions from clinic records
for all illnesses (most commonly respiratory, skin and ear
infections) assessed at the study clinic.
Children were classified according to standard defin-
itions as: underweight (weight-for-age z-score < 2 stand-
ard deviations (SD) from the 2006 WHO growth
reference26); stunted (height-for-age z-score < 2 SD);
and/or wasted (weight-for-height z- score < 2 SD).
Data analysis
We restricted this analysis to children who had at least one
diarrhoea episode and therefore had the opportunity to be
treated with antibiotics for diarrhoea. Because the propor-
tion of missing data for baseline and diarrhoea severity-
related covariates was 5% or less for all variables, we
imputed the median values of variables for individuals
and episodes with missing data (indicated in Table 1
footnote).
Logistic regression was used to calculate inverse prob-
ability of exposure weights stabilized by the marginal
probability of exposure.27 Confounding variables for the
exposure model were chosen by causal directed acyclic
graph28 to account for baseline characteristics and indica-
tions for treatment. We were particularly concerned about
confounding by diarrhoea episode severity, which was
associated with higher antibiotic use rates and might also
predict future diarrhoeal risk. We therefore included mul-
tiple characteristics of the diarrhoea episode to capture the
multifaceted concept of illness severity. The final exposure
model included episode number, socioeconomic status
defined from the modified Kuppuswamy scale,29,30 mater-
nal education, child sex, caesarean birth, low birthweight,
preterm birth, hospitalization at birth, antibiotics given at
birth and characteristics of the last diarrhoea episode: age,
Vesikari score,25 duration, hospitalization, fever, dehydra-
tion, bloody diarrhoea, underweight, stunted, wasted, ex-
clusive and any breastfeeding, zinc given, number of
previous antibiotic courses for any illnesses, number of
sick days between episodes, and other antibiotics given be-
tween episodes. Continuous variables were modelled flex-
ibly with restricted quadratic splines,31 and covariate
specifications were compared by Akaike’s information cri-
terion. To remove extreme weight values,32 weights were
censored at the 0.5th and 99.5th percentiles by resetting
the value of weights greater than the 99.5th percentile and
less than the 0.5th percentile to the value of the 99.5th and
0.5th percentile, respectively.
Table 1. Demographic characteristics of 434 children with at














Low 114 (68.7) 168 (62.7)
Medium 50 (30.1) 94 (35.1)
High 2 (1.2) 6 (2.2)
Maternal education
No formal education 67 (40.4) 93 (34.7)
Primary/middle school 52 (31.3) 97 (36.2)
Higher secondary school 42 (25.3) 69 (25.7)
College/polytechnic/
professional school
5 (3.0) 9 (3.4)
Poor household hygieneb 75 (45.2) 149 (55.6)
Crowding
High (> 4 people/room) 52 (31.3) 78 (29.1)
Medium (3.1–4 people/
room)
63 (38.0) 103 (38.4)
Low ( 3 people/room) 51 (30.7) 87 (32.5)
Child characteristics
Sex of child
Male 87 (52.4) 147 (54.9)
Female 79 (47.6) 121 (45.1)
Cesarean section 29 (17.5) 45 (16.8)
Low birthweightc 33 (20.3) 43 (16.3)
Preterm birthc 19 (11.7) 26 (9.9)
Baby kept in ICU at birth 9 (5.4) 23 (8.6)
Antibiotics at birthc 3 (1.9) 8 (3.1)
Age at first diarrhoea
<6 months 103 (62.0) 204 (76.1)
6 month–1 year 44 (26.5) 52 (19.4)
>1 year 19 (11.4) 12 (4.5)
Age (months) at stopping ex-
clusive breastfeeding (mean,
SD)
4.2 (2.0) 3.8 (2.1)
Age (months) at stopping all
breastfeeding (mean, SD)
17.4 (8.7) 16.2 (8.3)
ICU, intensive care unit. SD, standard deviation
aSocioeconomic status categories defined from the modified Kuppuswamy
scale.29,30
bPoor household hygiene was based a score of less than 12 on a scale de-
veloped from an assessment of water, food, and personal hygiene.46
cSeven missing values for low birthweight; 9 missing values for preterm
birth; 13 missing values for antibiotics at birth.
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We estimated inverse probability-weighted Kaplan-
Meier (KM) curves27,33 for the time to next diarrhoea
episode, comparing children who did and did not receive
antibiotics for the previous episode. The time scale33 was
from 48 h after the previous diarrhoea episode to the inci-
dent day of the next episode. Children were censored
at drop-out, death or the end of follow-up at 3 years of
age. We assumed person-time during which children were
temporarily unreachable was missing at random, and
drop-out was non-informative given the small proportion
of drop-outs (n¼ 50, 11.5% overall; n¼ 18, 4.1% between
the first and second diarrhoea episode). We assessed
each episode pair separately and then collapsed across
episodes.
We calculated the time difference and time ratio at 50%
diarrhoea-free survival, the median survival time, from
the weighted KM curves. Confidence intervals were con-
structed by bootstrap34 with 200 resamples at the level of
the individual to account for clustering of episodes within
children.
We also estimated hazard ratios, comparing the same
exposure groups using marginal structural Cox models33
with the same inverse probability weights. These models
were estimated by pooled logistic regression with adjust-
ment for time using a restricted quadratic spline.31
Correlation between outcomes from the same child was ac-
counted for using generalized estimating equations with a
robust variance estimator.
Effect measure modification
We assessed modification of the effect of antibiotics by
age at exposure by stratification. We also considered
the effect of specific antibiotics commonly given—
trimethoprim/sulfamethoxazole (cotrimoxazole) and ceph-
alosporins (97.4% of which were cefixime)by comparing
children receiving each drug with children given no
antibiotics.
Sensitivity analyses
To validate caregiver report of antibiotic treatment, we re-
peated analyses with alternative definitions of antibiotic
exposure. First, we restricted the exposed group to only
those children whose caregivers reported the name of a
confirmed antibiotic in the free-response section of the
questionnaire. Second, we considered children exposed if
either their caregiver reported that antibiotics were given
(by indicating yes/no) or if an antibiotic prescription was
recorded in clinic records during the diarrhoea episode.
Finally, we considered children exposed only if a con-
firmed antibiotic name was reported or if a prescription
was recorded in the clinic records.
To assess the impact of long episode duration contribu-
ting to shorter time between episodes, we repeated the
main analyses excluding all episode pairs where the first
episode lasted for more than 7 days (n¼ 194, 8.6% total;
n¼ 42, 9.8% among first episodes).
Figure 1. Incidence of diarrhoea by age (using restricted quadratic splines31) among 434 children in a birth cohort in Vellore, Tamil Nadu, India
2009–13.
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To assess whether antibiotics were associated with the
severity of subsequent diarrhoea when another episode
occurred, we estimated the effects of antibiotic treatment
for the previous episode on the severity and duration of the
next episode. In models weighted for the same covariates
as in the above analyses, we used inverse probability-
weighted linear regression with the Vesikari score and
number of days with diarrhoea as continuous outcomes.
We also estimated the adjusted relative risk for a severe
(Vesikari 11) and prolonged/persistent ( 7 days) next
episode using inverse probability-weighted log-binomial
regression.
Last, we compared the results from the main study with
two earlier cohorts of children from the same study
area.35,36 The earlier cohorts lacked complete records of
antibiotics given to treat non-diarrhoeal illnesses, and the
type of antibiotics given for diarrhoea were unknown. In
addition, the most recent earlier study was a smaller quasi-
experimental study, in which children were followed
once-weekly for only 2 years and enrolled after birth if still
exclusively breastfed.36 Despite these limitations, we pre-
sent the results from these cohorts for completeness.
Results
Almost all children in the birth cohort (434 of 497,
87.3%) had at least one diarrhoea episode and were
included in the analysis. Of these, 412, 393 and 384 chil-
dren completed the first, second and third study year of fol-
low-up respectively (drop-out rate of 11.5%). Six children
died during follow-up; two deaths were associated with
diarrhoea. Most children were of low socioeconomic status
(n¼ 282, 65%, Table 1) and approximately half had poor
household hygiene (n¼ 210, 48.4%). By 6 months of age,
most children had stopped exclusive breastfeeding
(n¼ 370, 85.3%) and had their first episode of diarrhoea
(n¼ 307, 70.7%). Children who received antibiotics were
slightly more likely to be from households with poor hy-
giene. These children stopped all breastfeeding on average
1 month earlier, and had their first diarrhoea episode at
younger ages (Table 1).
The total accumulated follow-up was 1013.3 person-
years, including 981.8 diarrhoea-free person-years
included as person-time at risk in analyses. Incidence of
diarrhoea was highest around 6 months of age, with an in-
cidence of 32.4 episodes per 100 person-months among
children between 5 and 7 months of age (Figure 1).
A total of 2295 diarrhoea episodes were reported, of
which 658 (28.9%) were treated with antibiotics. We
excluded 16 diarrhoea episodes (0.7%) due to missing
antibiotic treatment information. More than half of chil-
dren (n¼ 268, 61.8%) reported at least one antibiotic
course for diarrhoea, and 154 (35.5%) reported two or
more antibiotic courses for diarrhoea in the first 3 years of
life. Antibiotic treatment of diarrhoea was associated with
older age at the time of the episode and increased episode
severity and duration (Table 2). The most common antibi-
otic given was cotrimoxazole, accounting for 50.3% of
caregiver-reported antibiotics and 57.8% of antibiotics
prescribed at the study clinic for diarrhoea. Cefixime
accounted for another 24.6% of caregiver-reported
antibiotics and 34.5% of antibiotic prescriptions at the
clinic. All other antibiotics, such as fluoroquinolones, peni-
cillins and macrolides, were reported for less than 5% of
cases.
Table 2. Characteristics of diarrhoea episodes and their asso-
ciation with antibiotic treatment among 434 children in a birth











< 6 months 589 (25.8) 110 (16.7) 1.
6 mo.–1 yr. 701 (30.8) 213 (32.4) 1.90 (1.46, 2.47)
1–2 years 596 (26.2) 209 (31.8) 2.35 (1.80, 3.07)
2–3 years 393 (17.2) 126 (19.1) 2.05 (1.53, 2.76)
Severityc
Mild 1125 (49.4) 235 (35.7) 1.
Moderate 900 (39.5) 302 (45.9) 1.91 (1.57, 2.33)
Severe 221 (9.7) 104 (15.8) 3.37 (2.49, 4.55)
Very severe 33 (1.4) 17 (2.6) 4.02 (2.00, 8.08)
Durationd
Acute 2011 (88.2) 549 (83.4) 1.
Prolonged 234 (10.3) 93 (14.1) 1.76 (1.33, 2.32)
Persistent 34 (1.5) 16 (2.4) 2.37 (1.20, 4.67)
Bloody stools
No 2231 (97.9) 634 (96.4) 1.
Yes 48 (2.1) 24 (3.7) 2.52 (1.42, 4.47)
Fevere
No 1990 (87.3) 518 (78.7) 1.
Yes 289 (12.7) 140 (21.3) 2.67 (2.08, 3.43)
Dehydration
No 1652 (72.5) 410 (62.3) 1.
Yes 627 (27.5) 248 (37.7) 1.98 (1.63, 2.41)
Hospitalization
No 2219 (97.4) 623 (94.7) 1.
Yes 60 (2.6) 35 (5.3) 3.59 (2.13, 6.04)
aExcludes 16 episodes for which antibiotic treatment was unknown.
bOdds ratio for antibiotic treatment of diarrhoea episode by diarrhoea
characteristics.
cSeverity based on the Vesikari score. Mild: 1–5; moderate: 6–10; severe:
11–15; very severe: 16–20.
dDuration in days. Acute: 1–6 days; prolonged: 7–13 days; persistent:  14
days.
eCaregiver-reported.
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Effect on diarrhoea incidence
Of 434 children experiencing a first diarrhoea episode, we
excluded 3 children with missing antibiotic treatment and
1 child who dropped out on the first day following their
first episode. Among children who had a second diarrhoea
episode (n¼ 375, 87.2%), the median time to second diar-
rhoea episode was 10 weeks [interquartile range (IQR): 3,
20]. The crude difference in median time to second diar-
rhoea episode among children who were treated with anti-
biotics for their first episode (n¼84) compared with
children who were not treated (n¼ 289) was 2 weeks (me-
dian time difference (MTD): 2, 95% confidence interval
(CI): 8, 3). The crude hazard ratio from a Cox propor-
tional hazards model was 1.15 (95% CI: 0.77, 1.72).
Figure 2A shows inverse probability of treatment-
weighted Kaplan-Meier curves for time to second diar-
rhoea episode among children who were (n¼ 93) and were
not (n¼ 337) treated with antibiotics for their first episode.
Based on the weighted curves, children who received anti-
biotics for their first diarrhoea episode had their second
episode on average 8 weeks earlier (MTD: 8, 95% CI:
10, 3) or twice as soon (median time ratio (MTR):
0.50, 95% CI: 0.38, 0.79) as children who did not receive
antibiotics (Table 3). In a Cox proportional hazards model
weighted for the same covariates, the adjusted hazard ratio
was 1.38 (95% CI: 1.05, 1.82).
The effect of antibiotic treatment of the second diar-
rhoea episode on time to third diarrhoea was similar,
whereas effects in later episode pairs were smaller
(Figure 2B, Table 3). The overall adjusted time difference
and ratio when collapsing all episode pairs were 4 weeks
(95% CI: 9, 0) and 0.71 (95% CI: 0.44, 0.96), respect-
ively (Figure 2C, Table 3).
Effect measure modification
The effect of antibiotics on time to next diarrhoea was
greatest among children who were treated with antibiotics
for diarrhoea under 6 months of age compared with antibi-
otic treatment between 6 months and 1 year and after 1
year of age (Figure 3, Table 3). A shorter time to next diar-
rhoea was observed for both cotrimoxazole (MTD: 1,
Figure 2. Inverse probability of treatment-weighted Kaplan-Meier curves for time to next diarrhoea episode by antibiotic treatment for the previous
diarrhoea episode among 430 children from Vellore, Tamil Nadu, 2009–13. A. Weighted diarrhoea-free survival from first to second episode.
B. Weighted diarrhoea-free survival from second to third episode. C. Weighted diarrhoea-free survival for all episode pairs.
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95% CI: 7, 2) and cephalosporins (MTD: 3, 95% CI:
9, 0) compared with no antibiotics, though the effect was
smaller for cotrimoxazole (Figure S2, Table S1, available
as Supplementary data at IJE online).
Sensitivity analyses
Results under alternative exposure definitions were con-
sistent with the main analyses, though the effect size dimin-
ished as the definitions became less sensitive and more
specific (Figure S1, Table S1, available as Supplementary
data at IJE online). When excluding all previous episodes
with greater than 7 days’ duration, diarrhoea-free survival
curves were similar to main analyses, and time differences
and ratios were slightly larger in magnitude (Table S2,
available as Supplementary data at IJE online).
When subsequent diarrhoea occurred, the average
Vesikari score and duration of the second episode were
slightly lower among children who were treated with anti-
biotics during their first episode compared with those
who were not (Table S3, available as Supplementary data
at IJE online). Correspondingly, the risks for a severe or
prolonged/persistent second diarrhoea episode were lower
among these children. However, the absolute differences
in severity and duration were small (less than one point
on the Vesikari scale and less than 1 day, respectively)
and imprecise since few episodes were severe (10.4%) or
of long duration (11.5%). The results were consistent
when restricting to episodes which occurred under 6
months of age and when including all episode pairs (not
shown).
To validate our findings, we analysed data from two
previous cohorts conducted at this site.35–37 One study36
was conducted from 2008 to 2011 and included 160 chil-
dren with at least one diarrhoea episode. Prevalence of
antibiotic treatment of diarrhoea was lower, at 6.4% (50
of 785 total episodes with antibiotic treatment informa-
tion). The second study,35,37 conducted from 2002 to
2006, included 390 children who had at least one diar-
rhoea episode. Of 1812 diarrhoea episodes with known
antibiotic treatment, 27.7% (n¼ 502) were treated with
antibiotics. Information on antibiotic treatment for other
illnesses was missing. The weighted Kaplan-Meier curves
including all episode pairs from these earlier studies
were consistent with the results from the main study.
Combining all three cohorts, children who were
treated with antibiotics for their first diarrhoea
Table 3. Estimated effect of antibiotic treatment for the previous diarrhoea episode on time to next episode by episode pair and
age at first episode among 430 children in a birth cohort in Vellore, Tamil Nadu, India 2009–13
Antibiotics for
previous episode








1st to 2nd No 337 0. 1. 1.
Yes 93 8 (10, 3) 0.50 (0.38, 0.79) 1.38 (1.05, 1.82)
2nd to 3rd No 273 0. 1. 1.
Yes 94 7 (11, 1) 0.46 (0.29, 1.10) 1.53 (1.05, 2.23)
3rd to 4th No 234 0. 1. 1.
Yes 75 1 (11, 11) 1.07 (0.37, 1.90) 0.79 (0.54, 1.16)
>4th No 762 0. 1. 1.
Yes 393 2 (7, 5) 0.86 (0.57, 1.39) 1.23 (0.94, 1.61)
All No 1606 0. 1. 1.
Yes 655 4 (9, 0) 0.71 (0.44, 0.96) 1.35 (1.11, 1.64)
Age at first episode
< 6 months No 472 0. 1. 1.
Yes 108 4 (6, 0) 0.60 (0.40, 1.00) 1.72 (1.27, 2.32)
6–12 months No 491 0. 1. 1.
Yes 212 4 (9, 3) 0.76 (0.53, 1.22) 1.42 (1.14, 1.76)
 12 months No 643 0. 1. 1.
Yes 335 2 (10, 6) 0.91 (0.55, 1.32) 1.12 (0.82, 1.54)
aWeighted for episode number, socioeconomic status,29,30 maternal education, child sex, caesarean birth, low birthweight, preterm birth, hospitalization at
birth, antibiotics given at birth and characteristics of the last diarrhoea episode: age, Vesikari score,25 duration, hospitalization, fever, dehydration, bloody diar-
rhoea, underweight, stunted, wasted, exclusive and any breastfeeding, zinc given, number of previous antibiotic courses for any illnesses, number of sick days be-
tween episodes and other antibiotics given between episodes. The mean weight was 1.01 with range 0.29–16.18; after censoring at the 0.05th and 99.5th
percentiles, the mean was 0.99 with range 0.31–5.77.
bAssumes proportional hazards.
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episode had their second episode 3 weeks (MTD: 3, 95%
CI: 7, 1) or 20% (MTR: 0.80, 95% CI: 0.53, 1.07)
earlier than children who were not treated with
antibiotics (Figure S3, available as Supplementary data at
IJE online).
Discussion
This study provides the first evidence that antibiotic treat-
ment of diarrhoea may shorten the time between episodes,
especially among younger infants. These results are directly
applicable to diarrhoea treatment decisions, since antibi-
otic treatment is not essential for most cases of diarrhoea.
Specifically, according to Integrated Management of
Childhood Illness (IMCI) protocols,38 antibiotic treatment
was likely not indicated for a majority of cases in this study
since only few episodes (0.9%) were associated with
bloody stools. Antibiotics are a well-known cause of
antibiotic-associated diarrhoea,21 and we provide further
support for a sustained impact of antibiotics on diarrhoeal
risk. These results, which focus on antibiotic treatment of
diarrhoea specifically, are consistent with our recent work
demonstrating that any antibiotic exposure early in life is
associated with increased diarrhoeal rates.39
Antibiotic treatment of diarrhoea had the greatest im-
pact on time to next episode during the first two diarrhoea
episodes. This difference in effect may be due to young age
at earlier episodes and high overall antibiotic exposure by
the time of later episodes. The substantial increases in
magnitude of the adjusted effects compared with the crude
effect are largely due to removing confounding by age.
Because the microbiota is underdeveloped and more
susceptible to disturbances during infancy, antibiotic ex-
posures at the youngest ages may have the largest impact
on the microbiota, and correspondingly on diarrhoeal
risk.12,40 In addition, because of the high rates of antibiotic
use in this population, four-fifths (83%) of the population
had prior exposure to antibiotics by the third diarrhoea
episode. We hypothesize that antibiotics for diarrhoea are
likely to have the largest impact when they represent a ma-
jority of total antibiotic exposures, which occurs at earlier
episodes and younger ages.
The difference in effect on diarrhoeal risk between
cotrimoxazole and cefixime may result from their different
Figure 3. Stratified by age at first diarrhoea episode, inverse probability of treatment-weighted Kaplan-Meier curves for time to next diarrhoea epi-
sode among 430 children from Vellore, Tamil Nadu, 2009–13. A. First diarrhoea and antibiotic treatment below 6 months of age. B. First diarrhoea
and antibiotic treatment between 6 months and 1 year of age. C. First diarrhoea and antibiotic treatment after 1 year of age.
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spectrums of activity. Cotrimoxazole is broad-spectrum,
but notably does not affect anaerobes41 which dominate
the gut microbiota.42 Conversely, anaerobes are sensitive
to cefixime, and this drug is also more effective against
Gram-negative bacteria (especially Enterobacteriaceae)
common in the gut.41 Correspondingly, diarrhoea as a
drug-related adverse event is more commonly
reported for cefixime (15–20%) compared with
cotrimoxazole (< 1–10%).41,43 Similarly, cephalosporins
are one of the predominant drug classes noted to cause
antibiotic-associated diarrhoea.44,45 The activity of cefix-
ime against intestinal anaerobes may result in greater dis-
ruption of the gut microbiota and increased susceptibility
to diarrhoeal pathogens.
In the minority of diarrhoea episodes of bacterial aeti-
ology and for which antibiotics may have been indicated,
the reduction in time to subsequent diarrhoea may alterna-
tively have been due to a temporary benefit of antibiotics
followed by the recrudescence of the causative and antibi-
otic-susceptible agents, resulting in a second diarrhoea
episode.
As in any observational study, there is the potential for
bias due to uncontrolled confounding, including by local en-
vironmental factors associated with force of transmission
and pathogen-specific effects on the microbiome. However,
this cohort has the advantage of a detailed record of illness
characteristics that were likely the main indications for
treatment. This study was limited by potential misclassifica-
tion of exposure due to caregiver-reported treatment
information. However, we also incorporated antibiotic pre-
scriptions from clinic records, which likely captured the
majority of antibiotic exposures since the clinic was located
in the study area and provided free care and medicines.
There was concordance between caregiver-reported and
antibiotic prescriptions for diarrhoea: 78% of antibiotic pre-
scriptions during diarrhoea episodes were associated with
caregiver-reported antibiotic treatment. Further, our results
were consistent when we used alternative definitions of anti-
biotic exposure in sensitivity analyses.
Because there were few severe illnesses in our cohort,
we considered diarrhoea incidence the main outcome of
interest. Antibiotic treatment was associated with slightly
lower severity and duration of subsequent diarrhoea epi-
sodes, but the differences were small and imprecise.
Antibiotic treatment of diarrhoea may also have unin-
tended consequences for other illnesses such as respiratory
infections, and other potential effects should be taken into
account when making treatment decisions.
By providing evidence that antibiotics may cause direct
harm to children through an association with decreased
time to future diarrhoea episodes, these findings counter a
commonly held assumption among doctors and caregivers
that even if antibiotics are not strictly indicated, ‘at least
they can’t hurt’.11 Rational use of antibiotics has been
advocated to reduce antimicrobial resistance at the popula-
tion level, and rational use might also decrease future diar-
rhoeal risk among treated patients.
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